IMMUCELL CORP (ICCC)

US4525253062 - Common Stock

5.15  +0.15 (+3%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
17.47M18.57M19.24M15.34M13.72M
Cost Of Goods
13.60M10.92M10.59M8.48M6.98M
Gross Profit
3.87M7.65M8.66M6.86M6.74M
Operating Expenses
9.62M9.95M8.40M8.24M7.70M
Research and Development
4.39M4.49M4.17M4.35M3.69M
Selling, General, and Administrative Expenses
5.22M5.45M4.23M3.89M4.01M
Operating Income
-5.75M-2.30M260.00K-1.38M-950.00K
Interest Income/Expense
-379.03K-200.00K-300.00K-290.00K-310.00K
Other Income/Expense
110.000.000.00-170.00KN/A
Non Recurring Items
365.13KN/AN/A840.00KN/A
Income Before Taxes
-5.77M-2.49M-70.00K-1.03M-1.27M
Income Tax
4.63K10.00K10.00K-10.00K30.00K
Net Income
-5.77M-2.49M-80.00K-1.02M-1.30M
EBITDA
-3.03M190.00K2.72M970.00K1.32M
 
Per Share Data
EPS Diluted Total Ops
-0.75-0.32-0.01-0.14-0.19
Non GAAP EPS
-0.75N/AN/AN/AN/A
 
Statistics
Gross Profit Margin
22.15%41.20%45.01%44.72%49.13%
Profit Margin
-33.05%-13.41%-0.42%-6.65%-9.48%
Operating Profit Margin
-32.90%-12.39%1.35%-9.00%-6.92%

All data in USD

Charts